HaemTRIAL
@HaemTRIAL
Followers
26
Following
0
Media
0
Statuses
18
Haematology Academic Research Organisation
Joined September 2023
RT @MarcCarrier1: Have you ever wondered about the long-term risk of recurrence in patients with isolated SSPE?.New data suggest the risk m….
0
5
0
RT @MarcCarrier1: Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban….
0
82
0
RT @richardbuka: Very pleased to be involved with this project that is the first step on the ladder to interventional studies that can impr….
0
7
0
So right. Whilst AI is inevitable in healthcare…we first need to get the basics right. Computers that work and primary and secondary care databases that talk to each other are necessary bedrocks.
“No tech entrepreneur, no early adopter of AI, wants to talk about solving life’s boring problems. The tech dream is transformational and aspirational.”. Serendipitously timed for a global IT outage, here I argue in praise of boring AI @bmj_latest
0
0
0
RT @AdamMGrant: We don't need to debate whether it's better to be a generalist or a specialist. The world needs both. Specialists excel at….
0
1K
0
To help and express your interest in taking part– please give us 15 min of your time to fill out this simple 3-part survey.
1
0
1
HaemTRIAL is working up a study of venesection vs observation for patients with secondary polycythaemia but in order to design it we need to gauge the variability in practice and the perceived point of equipoise for these patients.
1
0
2
If the answer to any of these questions is ‘Yes’, then HaemTRIAL would love to hear from you.
1
0
1
Are you a clinician who sees patients with secondary polycythaemia?. Are you frustrated by the lack of an evidence base for treating these patients?. Does your practise differ from your colleagues when treating these patients?.
1
5
6
RT @ProfMakris: Article published in @RPTHjournal challenges the hypothesis that long covid is due to microclots. #….
rpthjournal.org
People with the post-COVID-19 condition suffer symptoms that persist beyond 12 weeks following acute COVID-19 infection. Fatigue, shortness of breath, and cognitive dysfunction (“brain fog”) are...
0
2
0
Yassi et al. Lancet Neurology 2024. Behind a paywall and I can't see how the study was powered. Headline results: Tranexamic Acid doesn't prevent haematoma expansion / improve functional status or mortality after ICH. But very small study with v wide CIs.
thelancet.com
Intravenous tranexamic acid did not reduce haematoma growth when administered within 2 h of intracerebral haemorrhage symptom onset. There were no observed effects on other imaging endpoints,...
0
0
0
Very exciting discussions with potential industry partners today. So encouraged.
0
0
0
0
3
0